XM does not provide services to residents of the United States of America.
M
M

McKesson


News

U.S. STOCKS Duolingo, Beyond Meat, Oil stocks

BUZZ-U.S. STOCKS ON THE MOVE-Duolingo, Beyond Meat, Oil stocks Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 all Street's main indexes rose nearly 2% on Thursday, bolstered by a better-than-expected jobs report that eased worries of an imminent slowdown in the world's largest economy.
C
M
U
U
M
R
P

U.S. STOCKS Parker Hannifin, Corpay, Sezzle

BUZZ-U.S. STOCKS ON THE MOVE-Parker Hannifin, Corpay, Sezzle Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes opened higher on Thursday, bolstered by better-than-expected jobs data that eased worries of an imminent slowdown in the world's largest economy.
M
U
U
M
R
P

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Parker-Hannifin Corp PH.N +10.1% Monolithic Power Systems Inc MPWR.OQ +8.9% Eli Lilly and Co LLY.N +7.6% Vistra Corp VST.N +7.6% ON Semiconductor Corp ON.OQ +7.0% Bottom Performers Percent Change Mckesson Corp MCK.N -12.7% Monster Beve
M
O
U
M
P

McKesson falls as Q1 revenue misses estimates

BUZZ-McKesson falls as Q1 revenue misses estimates ** Shares of drug distributor McKesson Corp MCK.N fall 11.2% to $548.2 ** Co late on Wednesday reported Q1 revenue below expectations due to soft demand for branded drugs, mainly AbbVie's ABBV.N arthritis drug Humira, and specialty medicines at its U.S. business ** U.S. pharmaceutical unit revenue came in at $71.7 billion, below analysts' expectations of $74.1 billion -LSEG data ** "Given that management did not reduce U.S.
M

Mckesson Corp reports results for the quarter ended in June - Earnings Summary

Mckesson Corp reports results for the quarter ended in June - Earnings Summary Mckesson Corp MCK.N reported quarterly adjusted earnings of $7.88​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $7.27. The mean expectation of sixteen analysts for the quarter was for earnings of $7.21 per share.
M

McKesson misses quarterly revenue as U.S. pharmaceutical segment weighs

McKesson misses quarterly revenue as U.S. pharmaceutical segment weighs Aug 7 (Reuters) - McKesson Corp MCK.N reported weaker-than-expected first-quarter revenue on Wednesday due to soft demand for branded and specialty drugs that dragged sales down in its U.S. pharmaceuticals segment. The drug distributor's pharmaceutical segment in the U.S. is its largest unit by revenue that sells drugs used to treat complex conditions such as cancer.
M

McKesson Q1 Adjusted EPS USD 7.88 Vs. IBES Estimate USD 7.21

BRIEF-McKesson Q1 Adjusted EPS USD 7.88 Vs. IBES Estimate USD 7.21 Aug 07 (Reuters) - McKesson Q1 revenue USD 79,283 million vs. IBES estimate USD 82,530 million. Q1 operating income USD 1,029 million Q1 EPS USD 7 Q1 adjusted net income USD 1,029 million vs. IBES estimate USD 940.8 million outlook FY adjusted EPS USD 31.75-32.55
M

What to Watch in the Day Ahead - Wednesday, August 7

What to Watch in the Day Ahead - Wednesday, August 7 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Walt Disney is scheduled to report a rise in third-quarter revenue, helped by strong performance of animated releases such as "Inside Out 2." Separately, Warner Bros Discovery is expected to rep
L
M

U.S. STOCKS IDEXX, Amgen, Airbnb

BUZZ-U.S. STOCKS ON THE MOVE-IDEXX, Amgen, Airbnb Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose over 1% on Tuesday, as investors looked for bargains after a global stock selloff and dovish comments from Federal Reserve officials lifted market sentiment.
A
A
B
I
U
U
F
M
R
U
V
M

U.S. STOCKS Lumen Technologies, Broadridge Financial, IDEXX

BUZZ-U.S. STOCKS ON THE MOVE-Lumen Technologies, Broadridge Financial, IDEXX Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose over 1% on Tuesday, as investors looked for bargains after a global stock selloff and dovish comments from Federal Reserve officials lifted market sentiment.
A
A
B
C
I
U
U
F
M
R
T
U
B
J
M

Leerink views Lilly and Sarepta as defensive stocks in turbulent market

BUZZ-Leerink views Lilly and Sarepta as defensive stocks in turbulent market ** Brokerages Leerink Partners says Eli Lilly LLY.N and Sarepta Therapeutics SRPT.O are among stocks it expects to outperform the broader market in "this turbulent period" of recession concerns ** Brokerage expects strong performance from the weight-loss and diabetes drug maker LLY on Wed, when it reports its earnings ** SRPT is a "a potential haven for investors seeking downside protection in a choppy market" due to po
A
B
M
T

Mckesson Corp <MCK.N> expected to post earnings of $7.21 a share - Earnings Preview

Mckesson Corp expected to post earnings of $7.21 a share - Earnings Preview Mckesson Corp MCK.N , MCK is expected to show a rise in quarterly revenue when it reports results on August 7 for the period ending June 30 2024 The Irving Texas-based company is expected to report a 10.8% increase in revenue to $82.53 billion from $74.48 billion a year ago, according to the mean estimate from 13 analysts, based on LSEG data.
M

U.S. Colgate-Palmolive, McKesson, Microsoft

U.S. RESEARCH ROUNDUP-Colgate-Palmolive, McKesson, Microsoft July 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Colgate-Palmolive, McKesson and Microsoft, on Tuesday. HIGHLIGHTS * Colgate-Palmolive Co CL.N : TD Cowen initiates coverage with buy rating; PT $110 * DR Horton Inc DHI.N : JP Morgan raises target price to $180 from $163 * IQVIA Holdings Inc IQV.N : Baird raises target price to $251 from $235 * McKesso
C
H
M
M
T
V
Z
F
A
M
A
C
C
D
I

McKesson, Cencora & Cardinal Health vying to buy Florida Cancer Specialists & Research Institute- Bloomberg News

MEDIA-McKesson, Cencora & Cardinal Health vying to buy Florida Cancer Specialists & Research Institute- Bloomberg News -- Source link: https://tinyurl.com/27qkdtlg -- Note: Reuters has not verified this story and does not vouch for its accuracy
M

U.S. Alphabet, Domino's Pizza, McKesson

U.S. RESEARCH ROUNDUP-Alphabet, Domino's Pizza, McKesson July 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alphabet, Domino's Pizza and McKesson, on Tuesday. HIGHLIGHTS * Alphabet Inc GOOGL.O : Jefferies raises target price to $220 from $215 * Domino's Pizza Inc DPZ.N : Baird raises to outperform; raises target to $580 from $530 * McKesson Corp MCK.N : Baird raises target price to $694 from $679 * Teleflex Inc T
A
A
C
C
G
M
C
A
C
T

Rite Aid bankruptcy plan approved, cutting $2 bln in debt

UPDATE 2-Rite Aid bankruptcy plan approved, cutting $2 bln in debt Updates throughout By Dietrich Knauth NEW YORK, June 28 (Reuters) - A U.S. bankruptcy judge on Friday approved Rite Aid's restructuring plan, allowing the pharmacy chain to cut its debt by $2 billion and turn over control to a group of lenders. U.S. Bankruptcy Judge Michael Kaplan approved Rite Aid's bankruptcy plan at a court hearing in Trenton, New Jersey, saying that the restructuring had saved the company from having to shut
M

Rite Aid seeks bankruptcy court approval to cut $2 billion debt

Rite Aid seeks bankruptcy court approval to cut $2 billion debt By Dietrich Knauth NEW YORK, June 27 (Reuters) - Rite Aid will ask a U.S. bankruptcy court to approve its restructuring plan on Thursday, seeking to cut $2 billion in debt and turn over control of the company to a group of its lenders. One of the largest U.S. pharmacy chains, Rite Aid has said in court filings that the restructuring is the best way to pay its creditors and emerge from bankruptcy.
M

US law firm Motley Rice appeals $396 mln opioid fee award

US law firm Motley Rice appeals $396 mln opioid fee award By Brendan Pierson June 24 (Reuters) - U.S. law firm Motley Rice is appealing its award of $396 million for its work on litigation against the drug industry over the opioid crisis that resulted in $46 billion in nationwide settlements. The firm said it would appeal the award, which represents 18.6% of a $2.13 billion pool of fees to be divided among dozens of law firms, in a notice filed Friday in Cleveland federal court.
T
W
M

Top law firms in US opioid lawsuits to get hundreds of millions in fees

Top law firms in US opioid lawsuits to get hundreds of millions in fees By Brendan Pierson June 7 (Reuters) - A court-appointed panel on Friday recommended how to divvy up a pool of $2.13 billion in legal fees from nationwide drug industry settlements over the U.S. opioid crisis, with top firms set to receive hundreds of millions of dollars. The panel gave national firm Motley Rice the largest share, with 18.6% of the funds, or $396 million.
T
W
M

Tesla director Gebbia says he discussed selling house to Musk

EXCLUSIVE-Tesla director Gebbia says he discussed selling house to Musk By Rachael Levy June 3 (Reuters) - Joe Gebbia, the Tesla TSLA.O director who exited a board committee that made key decisions about the car maker's future, told Reuters that CEO Elon Musk had discussed purchasing a house from his start-up and that he was concerned their friendship could be seized on to attack the committee's independence.
D
M
T
W
M



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.